Aliskiren in early postnatal life prevents hypertension and reduces asymmetric dimethylarginine in offspring exposed to maternal caloric restriction

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 16, Issue 3, 2015, Pages 506-513

  Hsu, Chien Ning ^a,b   Lee, Chien Te ^a   Huang, Li Tung ^a   Tain, You Lin ^a,c  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Aliskiren; asymmetric dimethylarginine; hypertension; nitric oxide; renin

Indexed keywords

ALISKIREN; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN RECEPTOR; ANGIOTENSINOGEN; ARGININE; DIPEPTIDYL CARBOXYPEPTIDASE; LOSARTAN; MESSENGER RNA; N(G),N(G) DIMETHYLARGININE; PRORENIN MAS; PRORENIN RECEPTOR; RENIN; UNCLASSIFIED DRUG; AMIDE; FUMARIC ACID DERIVATIVE; HISTONE DEACETYLASE; N,N-DIMETHYLARGININE;

AMINO ACID BLOOD LEVEL; ANGIOTENSIN II TYPE 2 RECEPTOR GENE; ANGIOTENSINOGEN GENE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALORIC RESTRICTION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE; HEART PROTECTION; HYPERTENSION; KIDNEY MASS; MALE; MAS GENE; MEAN ARTERIAL PRESSURE; NONHUMAN; PERINATAL PERIOD; PROGENY; PROTEIN EXPRESSION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; UPREGULATION; WEIGHT REDUCTION; ANALOGS AND DERIVATIVES; ANIMAL; BLOOD; BLOOD PRESSURE; BODY WEIGHT; DRUG EFFECTS; GENE EXPRESSION REGULATION; METABOLISM; NEWBORN; SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

AMIDES; ANIMALS; ANIMALS, NEWBORN; ARGININE; BLOOD PRESSURE; BLOTTING, WESTERN; BODY WEIGHT; CALORIC RESTRICTION; FEMALE; FUMARATES; GENE EXPRESSION REGULATION; HISTONE DEACETYLASES; HYPERTENSION; LOSARTAN; MALE; PEPTIDYL-DIPEPTIDASE A; RATS, SPRAGUE-DAWLEY;

EID: 84950317594     PISSN: 14703203     EISSN: 17528976     Source Type: Journal    
DOI: 10.1177/1470320313514123     Document Type: Article

References (22)

1. Vaziri ND,. Roles of oxidative stress and antioxidant therapy in chronic kidney disease and hypertension. Curr Opin Nephrol Hypertens 2004; 13: 93-99.
2. Wilcox CS,. Oxidative stress and nitric oxide deficiency in the kidney: A critical link to hypertension? Am J Physiol Regul Integr Comp Physiol 2005; 289: R913-R935.
3. Teerlink T, Luo Z, Palm F, et al. Cellular ADMA: Regulation and action. Pharmacol Res 2009; 60: 448-460.
4. Tain YL, Huang LT, Lin IC, et al. Melatonin prevents hypertension and increased asymmetric dimethylarginine in young spontaneous hypertensive rats. J Pineal Res 2010; 49: 390-398.
5. Tain YL, Lee WC, Hsu CN, et al. Asymmetric dimethylarginine is associated with developmental programming of adult kidney disease and hypertension in offspring of streptozotocin-treated mothers. PLoS One 2013; 8: e55420.
6. Kopkan L, Cervenka L,. Renal interactions of renin-angiotensin system, nitric oxide and superoxide anion: Implications in the pathophysiology of salt-sensitivity and hypertension. Physiol Res 2009; 58: S55-S67.
7. Woods LL, Ingelfinger JR, Nyengaard JR, et al. Maternal protein restriction suppresses the newborn renin-angiotensin system and programs adult hypertension in rats. Pediatr Res 2001; 49: 460-467.
8. Vehaskari VM, Stewart T, Lafont D, et al. Kidney angiotensin and angiotensin receptor expression in prenatally programmed hypertension. Am J Physiol Renal Physiol 2004; 287: F262-F267.
9. Sherman RC, Langley-Evans SC,. Early administration of angiotensin-converting enzyme inhibitor captopril, prevents the development of hypertension programmed by intrauterine exposure to a maternal low-protein diet in the rat. Clin Sci (Lond) 1998; 94: 373-381.
10. Sherman RC, Langley-Evans SC,. Antihypertensive treatment in early postnatal life modulates prenatal dietary influences upon blood pressure in the rat. Clin Sci (Lond) 2000; 98: 269-275.
11. Tain YL, Hsieh CS, Lin IC, et al. Effects of maternal l -citrulline supplementation on renal function and blood pressure in offspring exposed to maternal caloric restriction: The impact of nitric oxide pathway. Nitric Oxide 2010; 23: 34-41.
12. Tain YL, Hsu CN, Lin CY, et al. Aliskiren prevents hypertension and reduces asymmetric dimethylarginine in young spontaneously hypertensive rats. Eur J Pharmacol 2011; 670: 561-565.
13. Song R, Van Buren T, Yosypiv IV,. Histone deacetylases are critical regulators of the renin-angiotensin system during ureteric bud branching morphogenesis. Pediatr Res 2010; 67: 573-578.
14. Chen S, Bellew C, Yao X, et al. Histone deacetylase (HDAC) activity is critical for embryonic kidney gene expression, growth, and differentiation. J Biol Chem 2011; 286: 32775-32789.
15. Feng Y, Xia H, Santos RA, et al. Angiotensin-converting enzyme 2: A new target for neurogenic hypertension. Exp Physiol 2010; 95: 601-606.
16. National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals. Washington (DC): National Academies Press (US); 2011.
17. Goyal R, Goyal D, Leitzke A, et al. Brain renin-angiotensin system: Fetal epigenetic programming by maternal protein restriction during pregnancy. Reprod Sci 2010; 17: 227-238.
18. Sanoski CA,. Aliskiren: An oral direct renin inhibitor for the treatment of hypertension. Pharmacotherapy 2009; 29: 193-212.
19. Song R, Yosypiv IV,. (Pro)renin receptor in kidney development and disease. Int J Nephrol 2011; 2011: 247048.
20. Savoia C, Arrabito E, Parente R, et al. The direct renin inhibitor aliskiren improves vascular remodelling in transgenic rats harbouring human rennin and angiotensinogen genes. Clin Sci (Lond) 2013; 125: 183-189.
21. Christopherson KS, Hillier BJ, Lim WA, et al. PSD-95 assembles a ternary complex with the N-methyl-d-aspartic acid receptor and a bivalent neuronal NO synthase PDZ domain. J Biol Chem 1999; 274: 27467-27473.
22. Bian W, Sun L, Yang L, et al. Stabilization of the angiotensin-(1-7) receptor Mas through interaction with PSD95. Biochem J 2013; 453: 345-356.